Fludarabine
Childhood Langerhans Cell Histiocytosis
Milton S. Hershey Medical CenterSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Childhood Langerhans Cell Histiocytosis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Anti-Thymoglobulin, Rabbit Milton S. Hershey Medical Center | Phase 2 | CCC |
Evomela Milton S. Hershey Medical Center | Phase 2 | CCC |
Cyclophosphamide Milton S. Hershey Medical Center | Phase 2 | CCC |
Busulphan Milton S. Hershey Medical Center | Phase 2 | CCC |
Same molecule, other indications
Fludarabine is also rated in:
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →